Clinical TrialJun 2, 2026, 08:01 AM
Lantheus' LNTH-2513 PET/CT Wins SNMMI Image of the Year Award
AI Summary
Lantheus Holdings announced that an image generated using its investigational agent LNTH-2513 (18F-GP1) PET/CT was awarded SNMMI’s Image of the Year. This recognition follows investigator-initiated trial results evaluating LNTH-2513 PET/CT for detecting acute lower-extremity deep vein thrombosis (DVT), showing high diagnostic accuracy and good tolerability. The results highlight the potential of this thrombus-specific imaging approach to improve visualization and understanding of thromboembolic disease.
Key Highlights
- LNTH-2513 (18F-GP1) PET/CT image awarded SNMMI's Image of the Year.
- LNTH-2513 showed 95% sensitivity and 92% specificity for proximal DVT.
- Demonstrated 96% positive and 90% negative percent agreement for distal DVT.
- Identified concomitant pulmonary embolism in 22 of 46 patients.
- LNTH-2513 was well tolerated with no drug-related adverse events reported.
Price Impact
More from LNTH